Literature DB >> 571314

Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids.

M N El Makhzangy, V Wynn, D M Lawrence.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 571314     DOI： 10.1111/j.1365-2265.1979.tb03031.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  7 in total

1.  Facts about an implantable contraceptive: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

2.  [Concerning an implantable contraceptive: a memorandum of a WHO meeting].

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  Hirsutism and virilisation.

Authors:  J R Rentoul; C A Forrest; P Morley; R E Young
Journal:  Br Med J       Date:  1980-03-29

4.  Estrogen in patients with prostatic cancer. An assessment of the risks and benefits.

Authors:  P Henriksson
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 5.  Progestogens with antiandrogenic properties.

Authors:  Daniel Raudrant; Thomas Rabe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Effect of D-thyroxine on serum sex hormone binding globulin (SHBG), testosterone, and pituitary-thyroid function in euthyroid subjects.

Authors:  S Yosha; M Fay; C Longcope; L E Braverman
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

7.  Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis.

Authors:  Jeffrey T Jensen; Anne E Burke; Kurt T Barnhart; Carrie Tillotson; Marci Messerle-Forbes; Dawn Peters
Journal:  Contraception       Date:  2008-08-28       Impact factor: 3.375
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.